TXA | Placebo | RR (95% CI) | |||||
---|---|---|---|---|---|---|---|
N | n | (%) | N | n | (%) | ||
All patients | 6359 | 101 | (1.6) | 6280 | 102 | (1.6) | 0.98 (0.74–1.28) |
Severity | |||||||
Mild/moderate | 4066 | 41 | (1.0) | 3997 | 52 | (1.3) | 0.76 (0.52–1.16) |
Severe | 2264 | 60 | (2.7) | 2247 | 50 | (2.2) | 1.19 (0.82–1.73) |
Country income | |||||||
LMIC | 4375 | 50 | (1.1) | 4330 | 35 | (0.8) | 1.41 (0.92–2.17) |
HIC | 1984 | 51 | (2.6) | 1950 | 67 | (3.4) | 0.75 (0.52–1.07) |